The Official Journal of EuroPCR and the European Association of Percutaneous Coronary Interventions (EAPCI)

INTERVENTIONS FOR VALVULAR DISEASE AND HEART FAILURE

Thirty-day outcomes in patients at intermediate risk for surgery from the SAPIEN 3 European approval trial

EuroIntervention 2016;12:e235-e243 published online e-edition June 2016. DOI: 10.4244/EIJV12I2A37

1. Bichat Claude Bernard Hospital-Paris VII University, Paris, France; 2. Kerckhoff Clinic, Bad Nauheim, Germany; 3. University Clinics Eppendorf, Hamburg, Germany; 4. King’s College Hospital, London, United Kingdom; 5. Institut Hospitalier Jacques Cartie

Aims: This study sought to investigate outcomes of transcatheter aortic valve implantation (TAVI) with the SAPIEN 3 transcatheter heart valve (THV) in patients at intermediate risk for su

Sign in to read and download the full article

Forgot your password?
No account yet? Sign up for free!
Create my pcr account

Join us for free and access thousands of articles from EuroIntervention, as well as presentations, videos, cases from PCRonline.com

Read next article
Transapical mitral valve implantation after unclipping of a MitraClip: a glimpse into the future and treatment considerations in mitral regurgitation